IDS and mucopolysaccharidosis type 2: The MPS II patients had a clinical diagnosis of Hunter syndrome that was confirmed by biochemical analyses showing a high concentration of urinary GAGs and deficiency in iduronate 2-sulfatase activity in leukocytes.